Global pathology reach Dako operates under Agilent and serves hospitals and research laboratories worldwide with tissue-based diagnostic solutions, presenting a broad, enterprise-wide opportunity for cross-selling reagents, instruments, software, and expertise to large medical centers and networks.

Integrated cancer workflow As a brand focused on pathology solutions to determine effective cancer treatments, there is potential to upsell companion diagnostics, tissue assays, and digital pathology software to streamline diagnostic workflows in oncology departments.

Strategic backing Being owned by Agilent provides access to established sales channels, reputation, and customer trust, enabling leverage for expanded product adoption, service contracts, and bundled offerings across existing Agilent customers.

Healthcare scale The customer base includes large hospitals and laboratories, suggesting opportunities to target large-scale procurement, multi-site deployments, and ongoing service and maintenance contracts for instrumentation and reagents.

Market expansion potential With a global footprint and a focus on accuracy in tissue-based diagnostics, there is room to introduce new software analytics, automation solutions, and training services to boost throughput and diagnostic confidence in cancer care.